DAIICHI SANKYO COMPANY, LIMITED
A global pharmaceutical firm developing novel therapies with a focus on oncology and ADCs.
4568 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 中央区日本橋本町三丁目５番１号
- Website:
- https://www.daiichisankyo.co.jp/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Daiichi Sankyo is a global pharmaceutical company focused on the research, development, and delivery of innovative medical solutions. The company's core business revolves around creating novel therapies, with a primary strategic focus on oncology. It is a leader in the science of antibody-drug conjugates (ADCs), a class of targeted cancer drugs. Beyond oncology, its portfolio and development pipeline include treatments for cardiovascular diseases and other specialty areas. The company manufactures and markets a range of prescription medicines, vaccines, and over-the-counter healthcare products, aiming to contribute to the enrichment of quality of life for patients worldwide by creating new standards of care.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for DAIICHI SANKYO COMPANY, LIMITED and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-05 03:06 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 25.3 KB | |
| 2025-08-07 05:49 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 25.8 KB | |
| 2025-07-17 02:04 |
Prospectus
発行登録書（株券､社債券等）
|
Japanese | 24.8 KB | |
| 2025-07-09 02:32 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 25.2 KB | |
| 2025-06-24 06:02 |
Regulatory News Service
訂正発行登録書
|
Japanese | 8.9 KB | |
| 2025-06-24 05:36 |
Regulatory News Service
臨時報告書
|
Japanese | 25.7 KB | |
| 2025-06-23 08:40 |
Regulatory News Service
訂正発行登録書
|
Japanese | 8.9 KB | |
| 2025-06-23 07:44 |
Regulatory News Service
臨時報告書
|
Japanese | 31.3 KB | |
| 2025-06-20 07:20 |
Regulatory News Service
内部統制報告書－第20期(2024/04/01－2025/03/31)
|
Japanese | 23.5 KB | |
| 2025-06-20 07:20 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2025-06-20 07:19 |
Annual Report
有価証券報告書－第20期(2024/04/01－2025/03/31)
|
Japanese | 3.0 MB | |
| 2025-06-09 05:20 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 25.4 KB | |
| 2025-05-12 05:57 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 27.5 KB | |
| 2025-04-09 09:02 |
Regulatory News Service
訂正発行登録書
|
Japanese | 8.9 KB | |
| 2025-04-09 08:37 |
Regulatory News Service
臨時報告書
|
Japanese | 18.4 KB |
Automate Your Workflow. Get a real-time feed of all DAIICHI SANKYO COMPANY, LIMITED filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for DAIICHI SANKYO COMPANY, LIMITED via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}